CEFALY to Showcase Groundbreaking Migraine Device at Major Medical Meeting
Medical device innovator CEFALY Technology is set to demonstrate its game-changing neuromodulation migraine treatment at an upcoming prestigious gathering of healthcare professionals. Attendees will have the opportunity to explore how this device can provide relief from debilitating migraine headaches.
About the American College of Obstetricians and Gynecologists' Annual Meeting
This notable event, organized by the American College of Obstetricians and Gynecologists, is a key highlight in the medical calendar for obstetricians and gynecologists. It brings together over 60,000 members committed to advancing women's healthcare. The Annual Clinical and Scientific Meeting is a vital platform for sharing knowledge, treatments, and innovations in the field.
Innovative Technologies in Migraine Treatment
At Booth 102, CEFALY will present its FDA-cleared device, which has shown promise as a safe and effective treatment option for those who suffer from migraines, especially women during their childbearing years. CEO Jen Trainor-McDermott is enthusiastic about the opportunity to engage with clinicians, emphasizing the value of non-drug treatments that can improve quality of life.
The Challenges of Treating Migraines in Pregnant Women
Migraine is particularly common among women and can severely impact their well-being, especially during pregnancy. Many standard medications recommended for migraine management may carry risks that could affect fetal development, leading to a need for safer alternatives. CEFALY's approach focuses on providing a drug-free solution to these challenges.
Research Insights on Pregnancy and Migraines
Recent studies indicate a significant number of women may avoid pregnancy due to concerns about worsening migraines and the impact of medication on their child's development. Neuromodulation devices, like CEFALY, offer hope by targeting nerve pathways without the use of pharmaceuticals, minimizing the risk to both mother and child.
What CEFALY Offers to Patients
The CEFALY device, worn on the forehead, directly stimulates the trigeminal nerve, helping to alleviate migraine pain and prevent future attacks. This therapy has been reported to be effective, with many users experiencing no serious side effects during pregnancy. However, it's important to highlight that comprehensive studies on its effects specifically for pregnant users are still ongoing.
Building Connections and Knowledge in the Medical Community
CEFALY is also conducting research to gather more data on the benefits of non-medication options for pregnant women dealing with migraines. Medical Affairs Advisor Michael A. L. Johnson will be present at the ACOG meeting to discuss the significance of this research and to answer any questions regarding the utility of the CEFALY device in obstetric and gynecological care.
Expanding Awareness and Education
Attendees will be invited to try the CEFALY Connected device to experience its gentle neurostimulation firsthand. Furthermore, CEFALY will encourage clinicians to enroll in its comprehensive CEFALY Certified education program, which offers insights into external trigeminal nerve stimulation treatment methodologies.
Commitment to Women’s Health
CEFALY's initiative to connect with the ACOG membership is aimed at enhancing access to innovative migraine treatments for women. As one of the few non-pharmaceutical options available, CEFALY hopes to empower women in managing their migraines effectively.
About CEFALY Technology
CEFALY Technology prides itself on creating the CEFALY device, a clinically proven, over-the-counter device designed to reduce migraine frequency and relieve pain. Headquartered in Belgium, with U.S. operations in Darien, Connecticut, CEFALY focuses on developing cutting-edge technologies that elevate the standard of care in migraine treatments. Their mission centers around enabling migraine sufferers to regain control over their lives, fostering both health and happiness.
Frequently Asked Questions
What is the CEFALY device used for?
The CEFALY device is designed to help relieve migraine pain and reduce the frequency of migraine attacks using neuromodulation technology.
How does the CEFALY device work?
CEFALY works by delivering gentle neurostimulation to the trigeminal nerve, which can help alleviate migraine symptoms without the use of medications.
Is the CEFALY device safe for pregnant women?
While many women have reported using CEFALY during pregnancy without serious adverse effects, comprehensive studies on its safety for pregnant women are still being conducted.
Where can I find more information about CEFALY?
You can learn more about CEFALY and its offerings by visiting CEFALY.com, where extensive resources and information about the device are available.
Will there be live demonstrations of the CEFALY device?
Yes! CEFALY will be conducting live demonstrations at their booth during the ACOG Annual Clinical & Scientific Meeting, allowing attendees to experience the device firsthand.
